Virax Biolabs Group Ltd. (VRAX)
1.99
-0.12
(-5.69%)
USD |
NASDAQ |
Oct 08, 10:47
Virax Biolabs Group Price : 1.99 for Oct. 8, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 07, 2026 | 2.02 | 2.18 | 1.83 | 2.11 | 276364.0 |
| Oct 06, 2026 | 2.33 | 2.33 | 1.83 | 2.03 | 311083.0 |
| Oct 05, 2026 | 2.53 | 3.34 | 2.16 | 2.40 | 2.895M |
| Oct 02, 2026 | 2.21 | 2.25 | 2.13 | 2.20 | 19611.00 |
| Oct 01, 2026 | 2.18 | 2.374 | 2.18 | 2.24 | 30878.00 |
| Sep 30, 2026 | 2.25 | 2.27 | 2.13 | 2.184 | 19474.00 |
| Sep 29, 2026 | 2.27 | 2.395 | 2.04 | 2.23 | 97107.00 |
| Sep 28, 2026 | 2.35 | 2.35 | 2.30 | 2.314 | 5560.00 |
| Sep 25, 2026 | 2.38 | 2.60 | 2.38 | 2.395 | 13431.00 |
| Sep 24, 2026 | 2.277 | 2.47 | 2.277 | 2.44 | 20645.00 |
| Sep 23, 2026 | 2.52 | 2.60 | 2.50 | 2.55 | 14369.00 |
| Sep 22, 2026 | 2.38 | 2.65 | 2.285 | 2.50 | 51320.00 |
| Sep 21, 2026 | 2.48 | 2.54 | 2.145 | 2.31 | 70843.00 |
| Sep 18, 2026 | 2.50 | 2.58 | 2.49 | 2.54 | 14671.00 |
| Sep 17, 2026 | 2.53 | 2.60 | 2.50 | 2.53 | 17959.00 |
| Sep 16, 2026 | 2.59 | 2.59 | 2.45 | 2.49 | 23765.00 |
| Sep 15, 2026 | 2.66 | 2.775 | 2.58 | 2.59 | 24400.00 |
| Sep 14, 2026 | 2.59 | 2.75 | 2.58 | 2.61 | 31443.00 |
| Sep 11, 2026 | 2.77 | 2.84 | 2.60 | 2.67 | 42964.00 |
| Sep 10, 2026 | 2.73 | 2.92 | 2.70 | 2.85 | 72401.00 |
| Sep 09, 2026 | 2.66 | 2.76 | 2.63 | 2.73 | 38541.00 |
| Sep 08, 2026 | 2.60 | 2.66 | 2.56 | 2.63 | 29079.00 |
| Sep 04, 2026 | 2.54 | 2.635 | 2.54 | 2.625 | 21855.00 |
| Sep 03, 2026 | 2.625 | 2.69 | 2.52 | 2.56 | 40219.00 |
| Sep 02, 2026 | 2.56 | 2.61 | 2.54 | 2.545 | 25187.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Interpace Biosciences, Inc. | 6.00 |
| Akso Health Group | 1.15 |
| AstraZeneca PLC | 157.77 |
| GSK Plc | 46.18 |
| PD-Rx Pharmaceuticals, Inc. | 3.10 |
Price Related Metrics
| PS Ratio | 61.76 |
| PEG Ratio | -0.0003 |
| Earnings Yield | -849.8% |
| Market Cap | 1.153M |
| PEGY Ratio | -0.0003 |